Industry Trends

We previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have been...

Recently, open science has been making major strides in the news. Sure, people have been clamoring for full disclosure and availability of journal...

“The $1000 Pill.” “The Quest: $84,000 Miracle Cure Costs Less Than $150 to Make.” “A Billion a Year for Costly Drug Treatment.” These eye-catching...

Outsourcing drug discovery and development has become the key to making the entire drug research process more efficient. Over the past few years...

There’s a new trend in the biotech startup world, and that’s the increasing presence of biotech startup incubators across the country. Many...

Computational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug...

Last year, Scientist announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases. We know how...

We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...